The Changing Epidemiology of Pediatric Hemoglobinopathy Patients in Northern Alberta, Canada

Catherine Corriveau-Bourque1, Aisha A K Bruce

  • 1Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.

Insights

Canada lacks accurate data on hemoglobinopathy patients. This study reveals a growing pediatric population, primarily with sickle cell disease, necessitating increased healthcare resources and awareness.

Area of Science:

  • Hematology
  • Pediatric Health
  • Public Health

Background:

  • Hemoglobinopathies pose significant health risks globally.
  • Canada lacks comprehensive epidemiologic data on hemoglobinopathy prevalence.
  • Shifting immigration patterns are increasing the burden of these diseases in new regions.

Purpose of the Study:

  • To determine the epidemiology of pediatric hemoglobinopathy patients.
  • To assess the impact of population growth and immigration on healthcare needs.
  • To inform public health strategies and resource allocation.

Main Methods:

  • Retrospective chart review at Stollery Children's Hospital (2004-2014).
  • Analysis of patient demographics, diagnoses, and treatment outcomes.
  • Evaluation of trends in patient numbers and healthcare utilization.

Main Results:

  • Sickle cell disease accounted for 88% of cases.
  • A 3.5-fold increase in patient numbers was observed.
  • 70% of patients experienced diagnostic delays, and 30% developed severe complications.

Conclusions:

  • The growing pediatric hemoglobinopathy population requires urgent attention.
  • Healthcare systems must adapt to changing demographics and increased demand.
  • Advocacy for resources, provider education, and public awareness is crucial.
Abstract

Related Concept Videos

Pedigree Analysis01:35

Pedigree Analysis

Overview
91.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.7K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.8K